{"nct_id":"NCT00274742","title":"Safety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHL","status":"COMPLETED","status_verified_date":"2015-01","start_date":"2004-06","start_date_type":null,"primary_completion_date":"2011-08","primary_completion_date_type":"ACTUAL","completion_date":"2012-04","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AMGN"]}